Comparative effectiveness and predictors of response to tumour necrosis factor inhibitor therapies in rheumatoid arthritis

201296 citationsJournal Articlebronze Open Access

Authors

Over 1 year, we found no difference in effectiveness between adalimumab, etanercept and infliximab.

Good health and well-being

Published in: Lara D. Veeken

Volume 51, Issue 11, pp. 2020-2026

Field-Weighted Citation Impact: 8.79